· *Pfizer shares soared as much as 7.2% on Wednesday after the company announced positive early-stage trial results for its coronavirus vaccine.*
· *The BNT162b1 drug successfully created antibodies in all participants receiving 10, 30, or 100 microgram doses. *
· *Those taking two of the 10 or 30 microgram doses created...
Pfizer leaps more than 7% after releasing positive trial results for coronavirus vaccine
Business Insider
0 shares
1 views
You might like
Related news coverage
200-plus money managers pay thousands to set eyes on Jim Osman's stock buy list. Here are 2 he says are set to soar — and an under-the-radar IPO to keep a watch on
Business Insider
· Jim Osman, the founder of the Edge Group, arrives at his stock picks based off of longer-term, secular trends he's seeing emerge..
Is Coronavirus Vaccine Made From Fetal Cell Lines?
Eurasia Review
Advertisement
More coverage
President Trump Touts Vaccine Development On Visit To North Carolina
Newsy
Watch VideoPresident Trump on Monday touting progress on a coronavirus vaccine in North Carolina, a state hit hard by the..
-
Is the coronavirus vaccine made from fetal cell lines?
CNA
-
3M and Omnicom fall, while Pfizer and Cummins rise
SeattlePI.com
-
MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30
RTTNews
-
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day